KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Financing Activities (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Cash from Financing Activities for 16 consecutive years, with -$3.7 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Cash from Financing Activities fell 156.72% year-over-year to -$3.7 billion, compared with a TTM value of -$6.8 billion through Dec 2024, down 87.52%, and an annual FY2025 reading of $1.8 billion, up 126.52% over the prior year.
  • Cash from Financing Activities was -$3.7 billion for Q4 2024 at Thermo Fisher Scientific, down from -$1.2 billion in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $8.5 billion in Q4 2021 and bottomed at -$4.9 billion in Q2 2021.
  • Average Cash from Financing Activities over 5 years is -$284.2 million, with a median of -$471.0 million recorded in 2020.
  • The sharpest move saw Cash from Financing Activities surged 17379.59% in 2021, then plummeted 2406.58% in 2022.
  • Year by year, Cash from Financing Activities stood at -$49.0 million in 2020, then soared by 17379.59% to $8.5 billion in 2021, then tumbled by 71.76% to $2.4 billion in 2022, then tumbled by 159.72% to -$1.4 billion in 2023, then plummeted by 156.72% to -$3.7 billion in 2024.
  • Business Quant data shows Cash from Financing Activities for TMO at -$3.7 billion in Q4 2024, -$1.2 billion in Q3 2024, and -$115.0 million in Q2 2024.